Description
CHPG inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets ERK, mGlu5, and NF-κB.
Applications
CHPG can be used for research on chronic pain, anxiety, depression, and neurodegenerative disorders.
